7, 030, 118 B2 7, 091, 232 B2 7, 498, 409 B2 7, 524, 852 B2 7, 531, 547 B2 7, 754, 728 B2
7, 923, 554 B2 8, 012, 964 B2 8, 022, 077 B2 8, 455, 458 B2 8, 486, 952 B2 8, 637, 525 B2 …

US10266543B2 - Macrocyclic deaza-purinones for the treatment of viral infections - Google
Patents US10266543B2 - Macrocyclic deaza-purinones for the treatment of viral infections …

2016-07-12 Assigned to VERTEX PHARMACEUTICALS INCORPORATED reassignment
VERTEX PHARMACEUTICALS INCORPORATED ASSIGNMENT OF ASSIGNORS …

2013-07-29 Assigned to VERTEX PHARMACEUTICALS INCORPORATED reassignment
VERTEX PHARMACEUTICALS INCORPORATED ASSIGNMENT OF ASSIGNORS …

US9340557B2 - Substituted quinoxaline DNA-PK inhibitors - Google Patents
US9340557B2 - Substituted quinoxaline DNA-PK inhibitors - Google Patents Substituted …

(51) Int. Cl. CO7D 53/04(2006.01) International Search Report Received in the
corresponding PCT CO7D 49.8/00(2006.01) Application No. PCT/US2013/037811 (Aug. 29 …

US10039761B2 - Co-crystals and pharmaceutical compositions comprising the same - Google
Patents US10039761B2 - Co-crystals and pharmaceutical compositions comprising the same …

2014-11-24 Assigned to VERTEX PHARMACEUTICALS INCORPORATED reassignment
VERTEX PHARMACEUTICALS INCORPORATED ASSIGNMENT OF ASSIGNORS …

US10385054B2 - Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and
other diseases - Google Patents US10385054B2 - Pyrrolo[3,2-d]pyrimidine derivatives for the …

R? wherein R', R", X, Ring A, Ring B, and Ring C are as defined herein. Compounds of
Formula (I) are useful as inhibitors of DNA-PK. Also provided are pharmaceutical …